Press Release
-
- (2023-09-13) Samsung Chooses AimedBio for its First Domestic Investment with 'Life Science Fund'
- 2023.09.14
-
- (2023-07-06) Third pipeline selected for the 'KDDF' grant focuses on allergy
- 2023.07.18
-
- (2023-06-30) "The 1st Samsung Medical Center X AimedBio ADC Conference" ends in great success
- 2023.07.18
-
- (2023-06-30) Aimedbio signs another "ADC Co-development Agreement" with GeneQuantum
- 2023.07.18
-
- (2023-04-17) Aimedbio's poster presentation at "AACR 2023" (attached)
- 2023.07.18
-
- (2023-03-15) Aimed-GeneQuantum reveals 'FGFR3-ADC' preclinical data at "World ADC"
- 2023.07.18
-
- (2022-11-11) Aimedbio scores second 'KDDF' grant with its immune therapeutics targeting tumor-associated macrophages
- 2023.02.28
-
- (2022-09-13) Aimedbio joins ‘Lee Kun-hee’s support for children with cancers and rare diseases’ with its precision medicine platform AVATASCAN®
- 2023.02.28
-
- (2022-07-29) Aimedbio and GCcell collaborates on the next generation CAR-NK cell therapy development
- 2023.02.28
-
- (2022-07-27) Parkinson's treatment strategies and cell therapy research results shared at Aimedbio's 2nd Parkinson's Disease salon
- 2023.02.28
